Search Results 1701-1710 of 19435 for hemoglobin

1. Lurbinectedin + Doxorubicin In Leiomyosarcoma - Mayo Clinic

   Hemoglobin (Hgb) ≥ 8 g/dl (transfusion support permitted);; Platelet Count ≥ 100,000/mcL;; Total Bilirubin ≤ 1.5 × institutional upper limit of normal (ULN); ...

2. A Study to Evaluate Ramucirumab Plus Trifluridine/Tipiracil to Treat Patients with Previously-treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma - Mayo Clinic

   * Hemoglobin \>= 9.0 g/dL (obtained =\< 7 days prior to registration) * Total bilirubin =\< 1.5 x upper limit of normal (ULN) (obtained =\< 7 days prior to ...

3. A Study of Unesbulin Combined with Dacarbazine to Treat Advanced Leiomyosarcoma (LMS) - Mayo Clinic

   Hemoglobin ≥ 9 g/dL (packed red blood cell transfusion is allowed). Bilirubin < upper limit of normal (ULN). Aspartate aminotransferase or alanine ...

4. PRE-I-SPY Phase I/Ib Oncology Platform Program - Mayo Clinic

   - Hemoglobin ≥ 9.0 g/dL with no blood transfusion in the past 28 days - Total bilirubin ≤ 1.5 x the upper limit of normal (ULN) - Aspartate ...

5. A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) - Mayo Clinic

   Participant has diffusing capacity of the lung for carbon monoxide (DLCO) (corrected for hemoglobin) ≥ 50% predicted and/or forced expiratory volume in 1 ...

6. CSF1R And TAM Receptor Inhibition With Q702 - Mayo Clinic

   Hemoglobin ≥8.0 g/dL · Absolute neutrophil count (ANC) ≥1.0 x 109/L · Platelet count ≥80 x 109/L · WBC ≥2.5 x 109/L · Total bilirubin ≤1.5 x ULN · Alanine ...

7. Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer - Mayo Clinic

   Hemoglobin > 9.0 g/dL; Total bilirubin =< 1.5 x upper limit of normal (ULN); if patient has known Gilbert's syndrome, direct bilirubin =< 2.0 x ULN; Aspartate ...

8. Olaparib and Cediranib Maleate in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

   Hemoglobin >= 10 g/dL; Platelets >= 100,000/mcL; Total bilirubin =< 1.5 x the institutional upper limit of normal (ULN); Aspartate aminotransferase (AST) ...

9. Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery - Mayo Clinic

   Hemoglobin (Hgb) ≥9 g/dl without transfusion or epoetin dependency (≤7 days prior to assessment);; Absolute neutrophil count ³1.5 x 109/L;; Platelets ≥100 ...

10. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    Hemoglobin ≥ 8 g/dL. No transfusions are allowed within 72 hours prior to qualifying laboratory value. Recombinant human erythropoietin not permitted ...